Study to see if AI can help in prostate cancer battle

A STUDY is set to explore if artificial intelligence (AI) can help doctors make better decisions when it comes to treating prostate cancer.

- STORM NEWTON

While prostate cancer diagnosis has become safer and more accurate, it can still be challenging for medics to know how aggressive the disease is in individual patients.

This can sometimes lead to men having surgery or radiotherapy, when they could have been monitored.

The Vanguard Path study is led by researchers at the University of Oxford and funded with £1.9 million from the charity Prostate Cancer UK.

Experts will first test the technology - called ArteraAI Prostate Biopsy Assay - on prostate biopsy samples from men who have already been diagnosed and treated for the disease and have at least five years of followup data.

The study will compare how well the predictions made by the AI tool match what happened to patients in the real world.